Lantern Pharma Inc.LTRNNASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
|
|
|
|

Total earnings after all expenses, taxes, and interest

Latest
$-20.78M
↓ 98% below average
Average (6y)
$-10.49M
Historical baseline
Range
High:$-1.73M
Low:$-20.78M
CAGR
+51.4%
Consistent expansion
PeriodValueChange
2024$-20.78M-30.2%
2023$-15.96M-11.9%
2022$-14.26M-15.3%
2021$-12.36M-109.3%
2020$-5.91M-143.3%
2019$-2.43M-40.6%
2018$-1.73M-